PCH
OLMA icon

Polar Capital Holdings’s Olema Pharmaceuticals OLMA Stock Holding History

Polar Capital Holdings’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,602,970
Closed -$23.9M – 261
2026
Q1 		$23.9M Buy
1,602,970
+222,520
+16% +$4.95M 0.08% 134
2025
Q4 		$34.5M Buy
+1,380,450
New +$24.6M 0.13% 122
2024
Q3 		– Sell
-1,000,000
Closed -$10.8M – 307
2024
Q2 		$10.8M Buy
1,000,000
+250,000
+33% +$2.71M 0.06% 175
2024
Q1 		$8.49M Hold
750,000
– – 0.04% 209
2023
Q4 		$10.5M Hold
750,000
– – 0.06% 192
2023
Q3 		$9.26M Buy
+750,000
New +$7.64M 0.07% 188

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Polar Capital Holdings's OLMA Position: Q2 2026 in Review

Polar Capital Holdings sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 1,602,970 shares — an estimated $23.9M sold.

Polar Capital Holdings first reported a position in OLMA in Q3 2023 and held it in 6 quarters. The position peaked at $34.5M in Q4 2025. 184 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Polar Capital Holdings reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Polar Capital Holdings sold 1,602,970 Olema Pharmaceuticals shares in Q2 2026, an estimated $23.9M.
  • Polar Capital Holdings first reported a position in Olema Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • Polar Capital Holdings's Olema Pharmaceuticals position peaked at $34.5M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.